IL-21R

Overview

The IL-21 receptor is where the IFN-gamma priming signal and the IL-21 differentiation signal meet. It is arguably the most mechanistically important receptor on the DN2 pathway that the wiki had no page for until 2026-08-18, because it is the node at which IFN-γ’s epigenetic reprogramming is cashed out as an increased ability to respond to T cell help.

It is also the only receptor in this wiki that has been blocked in a human dengue B cell response.

Key Points from Literature

IFN-γ upregulates IL-21R — the licensing mechanism

Blockade evidence

Downstream requirement

Contradictions & Debates

★ The plasma IL-21 paradox. IL-21 is functionally required for ASC formation in vitro and IL-21R blockade removes 60% of the dengue plasmablast response — yet plasma IL-21 showed no correlation whatsoever with DN2 frequency in SLE patients (Spearman r=0.087, not significant), in the same study that found strong correlations for TNFα, CXCL10, IL-6 and IFN-γ (see Zumaquero2019 - IFN-gamma Programs T-bet-hi B Cells for ASC Differentiation, n=26 SLE).

The most economical reading is that IL-21 is delivered by cell contact at short range and its serum concentration is therefore uninformative — which would make surface IL-21R on the B cell, not plasma IL-21, the meaningful measurement. The same logic applies to the BAFF serum null in GarciaBates2013 - Plasmablast Response and Dengue Severity. This is a hypothesis the wiki holds, not a demonstrated result.

IL-21, IFN-gamma, STAT3, Peripheral Helper T Cell, Extrafollicular T Cell Help, DN2 B Cell, Plasmablast, Atypical B Cell Effector Output, ATAC-seq

Sources